Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: a pilot study.

Area of Science:

• Genomics
• Critical Care Medicine
• Bioinformatics

Background:

• Ventilator-associated pneumonia (VAP) is a significant cause of mortality and morbidity in critically ill patients.
• Early prediction of VAP can enable targeted preventive measures.
• Identifying at-risk patients is essential for improving outcomes.

Purpose of the Study:

• To develop a predictive model for VAP in critically injured trauma patients.
• To identify differentially expressed genes associated with VAP development.
• To explore gene expression patterns for VAP risk stratification.

Main Methods:

• Compared gene expression profiles of blood cells from VAP+ (n=10) and VAP- (n=10) trauma patients.
• Utilized ANOVA, hierarchical clustering, and principal component analysis (PCA) for gene analysis.
• Developed a logistic regression model incorporating key predictive genes.

Main Results:

• Identified 810 differentially expressed genes (P<0.05) between VAP+ and VAP- groups.
• Functional analysis revealed enrichment in protein translation, protease activity, and bacterial infection response pathways.
• A five-gene signature (PIK3R3, ATP2A1, PI3, ADAM8, HCN4) accurately categorized 95% of patients via hierarchical clustering and PCA.

Conclusions:

• A cross-validated logistic regression model accurately predicted VAP development in trauma patients.
• The identified five-gene signature shows promise for VAP risk assessment.
• Further validation in a larger patient cohort is recommended.